We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

Back to rankings

1,048 hedge funds and large institutions have $44.5B invested in Allergan plc in 2017 Q4 according to their latest regulatory filings, with 168 funds opening new positions, 313 increasing their positions, 479 reducing their positions, and 200 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 1,090 → 1,048 (-42)

16% less first-time investments, than exits

New positions opened: 168 | Existing positions closed: 200

18% less funds holding in top 10

Funds holding in top 10: 49 → 40 (-9)

21% less capital invested

Capital invested by funds: $56B → $44.5B (-$11.5B)

34% less call options, than puts

Call options by funds: $1.32B | Put options by funds: $2B

35% less repeat investments, than reductions

Existing positions increased: 313 | Existing positions reduced: 479

Holders
1,048
Holders Change
-42
Holders Change %
-3.85%
% of All Funds
23.76%
Holding in Top 10
40
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-18.37%
% of All Funds
0.91%
New
168
Increased
313
Reduced
479
Closed
200
Calls
$1.32B
Puts
$2B
Net Calls
-$681M
Net Calls Change
+$259M

Top Buyers

Rank Fund Capital Flow
1
SAM
Southeastern Asset Management
Tennessee
+$412M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$337M
3
AL
Appaloosa LP
New Jersey
+$283M
4
BG
Baupost Group
Massachusetts
+$276M
5
GCM
Glenview Capital Management
New York
+$207M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$699M
2
Jennison Associates
Jennison Associates
New York
-$387M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$267M
4
TCIM
TIAA CREF Investment Management
New York
-$244M
5
EVM
Eaton Vance Management
Massachusetts
-$206M
Name Holding Trade Value Shares
Change 		Change in
Stake
ID
1101
Integral Derivatives
New York
– -$2.26M -12,594 Closed
LSA
1102
L & S Advisors
California
– -$2.47M -12,049 Closed
Marshall Wace
1103
Marshall Wace
United Kingdom
– -$2.44M -11,927 Closed
CI
1104
Cowen Inc
New York
– -$2.42M -11,800 Closed
NLI
1105
Nippon Life Insurance
Japan
– -$2.36M -11,507 Closed
GC
1106
Grimes & Company
Massachusetts
– -$2.33M -11,395 Closed
LGC
1107
Laurel Grove Capital
California
– -$2.26M -11,028 Closed
ACM
1108
Advisors Capital Management
New Jersey
– -$2.25M -10,970 Closed
EAMA
1109
EFG Asset Management (Americas)
Florida
– -$2.21M -10,774 Closed
PJSIMP
1110
P.J. Schmidt Investment Management (PJS)
Wisconsin
– -$2.19M -10,696 Closed
SM
1111
SLS Management
New York
– -$2.13M -10,400 Closed
CG
1112
Cutler Group
California
– -$1.85M -10,334 Closed
SWM
1113
SVA Wealth Management
Wisconsin
– -$2.1M -10,266 Closed
LI
1114
Longer Investments
Arkansas
– -$2.09M -10,203 Closed
CPA
1115
Capital Planning Advisors
California
– -$2.04M -9,949 Closed
RA
1116
Rational Advisors
New York
– -$1.99M -9,712 Closed
HCMT
1117
Highland Capital Management (Texas)
Texas
– -$1.99M -9,700 Closed
SAM
1118
Security Asset Management
New York
– -$1.95M -9,513 Closed
CNC
1119
Citizens & Northern Corp
Pennsylvania
– -$1.7M -8,295 Closed
DM
1120
Delphi Management
Massachusetts
– -$1.62M -7,884 Closed
LCM
1121
Landscape Capital Management
New Jersey
– -$1.61M -7,847 Closed
SCI
1122
Stableford Capital II
Arizona
– -$1.6M -7,804 Closed
HBT
1123
Hills Bank & Trust
Iowa
– -$1.59M -7,779 Closed
JMH
1124
J.M. Hartwell
New York
– -$1.59M -7,750 Closed
TCM
1125
Tuttle Capital Management
Connecticut
– -$1.58M -7,712 Closed
43 44
45
46 47

AGN Hedge Fund Activity: Q4 2017 in Review

1,048 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q4 2017, worth a combined $44.5B — down 21% from $56B a quarter earlier.

Sellers outnumbered buyers: 200 funds closed out of AGN and 168 opened new positions — a net loss of 32 holders — while 479 trimmed existing stakes and 313 added.

The largest buyer was Southeastern Asset Management, opening a new position worth an estimated $412M. The largest seller was Fidelity Investments, cutting an estimated $699M.

  • 1,048 institutional investors held Allergan plc (AGN) as of Q4 2017, down from 1,090 in Q3 2017.
  • Funds reported $44.5B of Allergan plc stock for Q4 2017, down 21% quarter-over-quarter.
  • 168 funds opened new Allergan plc positions in Q4 2017 and 200 closed out, a net change of -32 holders.
  • The largest Allergan plc buyer in Q4 2017 was Southeastern Asset Management, an estimated $412M added.
  • The largest Allergan plc seller in Q4 2017 was Fidelity Investments, an estimated $699M sold.

Based on aggregated 13F filings for Q4 2017.